Agios Pharmaceuticals (AGIO) shares soared 17.7% in the last trading session to close at $44.01. The move was backed by solid ...
Agios stock jumps after the FDA accepts and grants priority review to its sNDA for mitapivat in sickle cell disease, with a ...